Berlin Buch

Berlin-Buch is an internationally renowned science, medicine, and technology location in the northeast of Berlin. It is one of Berlin's places of the future. Around 6,500 people in the healthcare industry work at this location. The centerpiece is the 32 ha Campus Berlin-Buch, which houses excellent research institutes and one of the largest biotech parks in Germany. With its clear focus on biomedicine, it offers outstanding innovation and growth potential. The EU, the federal government and the state have invested over 650 million euros of public funding since 1992. The clinics on-site ideally complement the work being done here.

Industries

• Medicine & Healthcare
• Life Sciences & Biotechnology

Campus Berlin-Buch

Excellence in science and research

• International campus with around 3,000 employees from 60 nations, including 1,200 scientists
• Unique combination of basic research in molecular medicine and molecular pharmacology with patient-oriented research
• The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) is one of the top life science research institutions worldwide. The internationally renowned Leibniz Research Institute for Molecular Pharmacology (FMP) is the only non-university institution in Germany working in pharmaceuticals research
• Close cooperation on site with clinics, university outpatient departments of the Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH), training of natural scientists and physicians in translational medicine
• Hightech platforms for genomics, proteomics, and metabolomics, ultra-high-field MRIs, advanced light microscopy, Kryo-EM, NMR spectroscopy, and a screening unit for drug discovery including medicinal chemistry

Innovations in biotechnology and medical technology

• BiotechPark Berlin-Buch with Innovation and Start-up center
• 75 companies with about 850 employees
  Areas of focus:
  • molecular biological diagnostic and therapeutic procedures
  • development of new drug therapies
  • drug delivery systems
  • service for the pharmaceuticals industry, research, and biotechnology
  • medical technology
• outstanding potential for cooperation with research and hospitals
• Access to professional events, industry and service networks and the above-mentioned high-tech platforms
• comprehensive services for start-ups and companies moving to Berlin
• 39,000 m² of industry-specific laboratory and office space (laboratories up to security level 3) including the new startup center BerlinBioCube
• immediately available space at attractive rental conditions
• Expansion areas for businesses: 9 hectares
• Companies (selection): iST Innuscreen, Celares, Congen, Eckert & Ziegler, emp Biotech, Glycotope, Invitek Molecular, Silence Therapeutics, T-knife, Cambrium
• Glass laboratory academy (continuing education)

Campus life: Work and relax in green surroundings

• Short distances and close interaction with the life science community
• Park with guiding concept of a Green Health Campus
• Campus-wide health management, gym
• Cafeteria, barista café, food trucks
• Day care center, holiday care in the school laboratory
• Free campus bikes

Hospital Campus

Clinical expertise

• Three hospitals with more than 60 departments for maximum and specialised healthcare offer a total of approximately 1,200 beds:
  • Helios Clinic Berlin-Buch
  • Evangelical Lung Clinic Berlin
  • Immanuel Hospital Berlin (specialists in rheumatology)
• Numerous certified center
• Approx. 220,000 patients per year (both inpatient and outpatient)
• Akademie der Gesundheit Berlin/Brandenburg e. V., a training center for the health professions (initial training, continuing education, and degree courses)

Location management

Campus Berlin-Buch GmbH (CBB) develops and operates Campus Berlin-Buch. It coordinates with research, hospitals, business, administration, politics, and the public in and around the campus. Together with Berlin Partner, the Berlin Senate, the district of Pankow, and other regional stakeholders, CBB is committed to attracting innovative biotech and medical technology companies and developing Berlin-Buch into an attractive Green Health City.